ArticleFrontiers in oncology2026
Systems approach to integrative oncology in breast cancer care: service design, delivery and patient experiences from a UK center.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer affects 2.3 million women annually worldwide, with survivors experiencing substantial unmet supportive care needs around symptom management, lifestyle support, psychological wellbeing, sexual health and survivorship. Integrative oncology (IO) is a patient-centered, evidence-informed approach combining lifestyle and mind-body interventions, natural products and complementary therapies alongside standard cancer treatment, supported by Society for Integrative Oncology and American Society of Clinical Oncology (SIO-ASCO) guidelines, but UK service delivery and patient experience data are limited. Methods: We conducted a multi-component study combining (i) a four-year electronic healthcare record (EHR) analysis of breast cancer (BC) patients attending Synthesis Clinic, a UK physician-led multidisciplinary integrative oncology service, between January 2022 and March 2026; and (ii) a cross-sectional patient survey of 232 women diagnosed with breast cancer, in collaboration with the National Centre for Integrative Oncology (NCIO) and the UK Building Resilience in Breast Cancer (BRiC) Centre, capturing experience of standard oncological care alone (n=211) and of combined standard plus integrative oncology care (n=21). Results: EHR analysis identified 182 women (mean age 50.3 years; 45.6% ever-metastatic; 20.3% triple-negative). Modality engagement was anchored on nutrition (95.0%) and integrative oncology physician consultations (55.9%), with smaller subgroups accessing intravenous nutrient therapy (20.9%), mistletoe therapy (13.7%), emotional wellbeing support (13.2%) and other modalities. In the standard care survey, unmet need exceeded 60% across seven supportive care domains, peaking at 85% for sleep and 83% for sexual health. Within-patient comparison in the IO cohort showed unmet need reduced to 0% in 11 of 13 directly comparable domains, with reductions exceeding 50 percentage points in 8 domains. 76% of IO cohort respondents rated integrative care as extremely important and 88% rated quality as very high or high. Conclusions: A structured, multidisciplinary, physician-led integrative oncology service is feasible in the UK and may help address guideline-aligned supportive care domains that are systematically under-delivered within standard oncological care. Substantial sociodemographic inequities in access remain and are the explicit focus of the NCIO charity service development. Our findings may also support the case for developing multidisciplinary integrative oncology hubs as specialist community centers within the NHS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.